About Pharma Excipients
“The current predicament has uncovered some structural weaknesses from the EU’s medicines offer chain plus a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She suggested that supply chain concerns be resolved